iShares Biotechnology ETF (NASDAQ:IBB) Shares Sold by Kovack Advisors Inc.

Kovack Advisors Inc. reduced its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 6.2% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,956 shares of the financial services provider’s stock after selling 130 shares during the period. Kovack Advisors Inc.’s holdings in iShares Biotechnology ETF were worth $285,000 as of its most recent SEC filing.

Several other institutional investors also recently made changes to their positions in the stock. Blue Fin Capital Inc. increased its holdings in shares of iShares Biotechnology ETF by 0.7% in the 2nd quarter. Blue Fin Capital Inc. now owns 10,516 shares of the financial services provider’s stock worth $1,443,000 after acquiring an additional 74 shares during the period. Security National Bank of SO Dak increased its stake in shares of iShares Biotechnology ETF by 0.7% in the second quarter. Security National Bank of SO Dak now owns 10,461 shares of the financial services provider’s stock valued at $1,436,000 after purchasing an additional 75 shares during the period. SPC Financial Inc. raised its holdings in shares of iShares Biotechnology ETF by 2.4% during the third quarter. SPC Financial Inc. now owns 3,265 shares of the financial services provider’s stock valued at $475,000 after buying an additional 75 shares during the last quarter. Werba Rubin Papier Wealth Management boosted its position in shares of iShares Biotechnology ETF by 2.7% during the third quarter. Werba Rubin Papier Wealth Management now owns 2,918 shares of the financial services provider’s stock worth $425,000 after buying an additional 76 shares during the period. Finally, Main Street Financial Solutions LLC grew its holdings in iShares Biotechnology ETF by 1.0% in the 2nd quarter. Main Street Financial Solutions LLC now owns 8,002 shares of the financial services provider’s stock worth $1,098,000 after buying an additional 82 shares in the last quarter. 62.45% of the stock is owned by institutional investors.

iShares Biotechnology ETF Stock Performance

IBB opened at $133.38 on Friday. iShares Biotechnology ETF has a 12 month low of $116.70 and a 12 month high of $150.57. The stock’s 50 day moving average price is $144.49 and its 200 day moving average price is $141.59.

iShares Biotechnology ETF Dividend Announcement

The business also recently disclosed a dividend, which was paid on Monday, September 30th. Investors of record on Wednesday, September 25th were paid a dividend of $0.2005 per share. The ex-dividend date was Wednesday, September 25th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.